Retour
Fourchette du Jour
102,24 €
107,84 €
Fourchette 52 Semaines
73,16 €
130,23 €
Volume
946 605
Moyenne 50J / 200J
113,40 €
/
99,38 €
Clôture Précédente
100,99 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -33,1 | 0,4 |
| P/B | 9,5 | 2,9 |
| ROE % | -26,4 | 3,8 |
| Net Margin % | -37,0 | 3,9 |
| Rev Growth 5Y % | 14,6 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 14,62% annually over 5 years — strong growth
Debt/Equity of 0,21 — conservative balance sheet
Negative free cash flow of -54,01M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17,71%
Capital efficient — spends only 1,51% of revenue on capex
Croissance
Revenue Growth (5Y)
14,62%
Revenue (1Y)32,33%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-26,38%
ROIC-18,81%
Net Margin-36,99%
Op. Margin-39,33%
Sécurité
Debt / Equity
0,21
Current Ratio4,69
Interest Coverage-43,06
Valorisation
P/E Ratio
-33,06
P/B Ratio9,46
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32,33% | Revenue Growth (3Y) | 26,98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 14,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 507,44M | Net Income (TTM) | -187,69M |
| ROE | -26,38% | ROA | -21,01% |
| Gross Margin | 55,72% | Operating Margin | -39,33% |
| Net Margin | -36,99% | Free Cash Flow (TTM) | -54,01M |
| ROIC | -18,81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,21 | Current Ratio | 4,69 |
| Interest Coverage | -43,06 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -33,06 | P/B Ratio | 9,46 |
| P/S Ratio | 12,23 | PEG Ratio | -1,87 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 6,21B | Enterprise Value | 6,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 507,44M | 383,48M | 314,71M | 282,86M | 294,01M |
| Net Income | -187,69M | -146,37M | -134,66M | -99,20M | -49,59M |
| EPS (Diluted) | -3,28 | -2,77 | -2,78 | -2,09 | -1,07 |
| Gross Profit | 282,76M | 289,45M | 239,14M | 213,88M | 227,38M |
| Operating Income | -199,60M | -122,37M | -128,70M | -82,31M | -32,87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 893,49M | 974,76M | 940,41M | 1,07B | 1,13B |
| Total Liabilities | 237,33M | 207,83M | 478,65M | 544,16M | 541,68M |
| Shareholders' Equity | 656,16M | 766,93M | 461,77M | 530,01M | 587,15M |
| Total Debt | 139,64M | 105,87M | 383,74M | 382,91M | 383,39M |
| Cash & Equivalents | 90,81M | 169,63M | 93,47M | 119,53M | 100,71M |
| Current Assets | 474,98M | 449,79M | 395,46M | 443,86M | 486,13M |
| Current Liabilities | 101,28M | 75,13M | 74,01M | 72,36M | 63,36M |